Wisconsin Governor Proposes Healthcare Cost Relief Plan

Evers seeks bipartisan support for 2026 legislative package to lower out-of-pocket costs

Published on Feb. 12, 2026

Wisconsin Governor Tony Evers is urging bipartisan support for a 2026 legislative package aimed at lowering out-of-pocket healthcare costs for state residents. The plan would cap insulin copays at $35, eliminate sales tax on over-the-counter medications, and create new oversight boards to review prescription drug prices. Evers has criticized federal Medicaid cuts and the lapse of Affordable Care Act tax credits, which he says are contributing to rising healthcare costs in 2026.

Why it matters

Healthcare affordability is a major concern for many Wisconsinites, especially as some face higher premiums following the expiration of enhanced ACA tax credits. Evers' proposal aims to provide relief and increase oversight to address rising out-of-pocket costs.

The details

Evers' 2026 legislative package includes capping insulin copays at $35, eliminating sales tax on over-the-counter medications, and creating new oversight boards to review prescription drug prices. The plan also proposes auditing insurers with high claim denial rates, limiting prior authorization requirements, and expanding consumer protections against surprise billing.

  • Evers is urging bipartisan support for the 2026 legislative package.

The players

Tony Evers

The Democratic governor of Wisconsin who is proposing the healthcare cost relief plan.

Donald Trump

The former U.S. president whose administration Evers has criticized over federal Medicaid cuts and the lapse of ACA tax credits.

Got photos? Submit your photos here. ›

What’s next

The governor will need to work with the state legislature to pass the proposed healthcare cost relief package in 2026.

The takeaway

Governor Evers' plan aims to provide much-needed relief for Wisconsinites facing rising healthcare costs, particularly as enhanced ACA tax credits expire. The proposal focuses on capping insulin copays, eliminating sales tax on over-the-counter medications, and increasing oversight of prescription drug prices and insurance practices.